NoW NHS Libraries logo

NOW Library Service



North West
Knowledge and Library Services




Amazon cover image
Image from Amazon.com

Drugs during pregnancy and lactation [electronic resource] : treatment options and risk assessment / edited by Christof Schaefer, Paul Peters, and Richard K. Miller.

Contributor(s): Publication details: Amsterdam : Academic Press, 2014.Edition: Third editionDescription: 928 pagesContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9780124079014 (e-book)
  • 9780124080782 (hbk.) :
Subject(s): Genre/Form: DDC classification:
  • 618.32 23
LOC classification:
  • RG627.6.D79 D7 2014
Online resources: Available additional physical forms:
  • Also available in printed form ISBN 9780124080782
Contents:
1. General Commentary on drug therapy and drug risks in pregnancy 2. Specific drug therapties during pregnancy 2.1 Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications 2.2 Allergy and hyosensitization therapy 2.3 Antiasthmatic and cough medication 2.4 Nausea and vomiting in pregnancy 2.5 Gastro-intestinal medications, hyoplipidemic agents and spasmolytics 2.6 Anti-infective Agents 2.7 Vaccines and immunoglobulins 2.8 Heart and blood medications 2.9 Anticoagulants, thrombocyte aggregation inhibitors, fibrinolyrics,and volume replacement agents 2.10 Epilepsy and antiepileptic medications 2.11 Psychotropic drugs 2.12 Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease 2.13 Antineoplastic drugs 2.14 Uterine contraction agents, tocolytics, vaginal therapeutics and local contraceptives 2.15 Hormones 2.16 General and local anesthetics and muscle relaxants 2.17 Dermatological medications and local therapeutics 2.18 Vitamins, minerals and trace elements 2.19 Herbs during pregnancy 2.20 Diagnostic agents 2.21 Recreational drugs 2.22 Poisonings and toxins 2.23 Occupational, industrial and environmental agents 3. General commentary on drug therapy and drug risk during lactation 3.1 The advances of breastfeading versus the risks of maternal medication 3.2 The passage of medication into the mother's milk 3.3 Infant characteristics 3.4 Milk plasma ratio 3.5 Amount of medication in the milk and relative dose 3.6 Toxicity of medications in the mother's milk 3.7 Medications that affect lactation 3.8 Breastfeeding support 4. Specific drug therapies during lactation 4.1 Analgesics, antiphlogistics and anesthetics 4.2 Antiallergics, antiasthmatics and antitussives 4.3 Gastrointestinal drugs 4.4 Anti-infectives 4.5 Vaccines and immunoglobulins 4.6 Cardiovascular drugs and diuretics 4.7 Anticoagulants, thrombocyte aggregation inhibitors and fibrinolytics 4.8 Antiepileptics 4.9 Psychotropic drugs 4.10 Immunomodulating and antineoplastic agents 4.11 Hormones and hormone antagonists 4.12 Dermatological medication and local therapeutics 4.13 Alternative remedies, vitamins, and minerals 4.14 Contrast media, radionuclides and diagnostics 4.15 Infections during breastfeeding 4.16 Recreational drugs 4.17 Plant toxins 4.18 Industrial chemicals and environmental contaminants 4.18.1 Persistent organochlorine compounds (pesticides, polychlorinated biphenyls and dioxins) 4.18.2 Mercury 4.18.3 Lead 4.18.4 Cadmium 4.18.5 Other contaminants 4.18.6 Breasfeeding despite environmental contaminants? 4.18.7 Breastfeeding and the workplace
Summary: This work presents the state of knowledge about drugs in pregnancy. In each chapter information is presented separately for two different aspects of the problem seeking a drug appropriate for prescription during pregnancy, and assessing the risk of a drug when exposure has already taken place. Drugs During Pregnancy and Lactation, 3 rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new medicinal products, this edition is a comprehensive resource covering latest knowledge and findings related to drugs during lactation and pregnancy. Provides evidence-based recommendations to help clinicians make appropriate recommendations Uniquely organized and structured according to drug class and treatment indications to offer authoritative clinical content on potential adverse effects Highlights new research developments from primary source about working mechanism of substances that cause developmental disorders
Holdings
Item type Home library Class number URL Status Notes Date due Barcode
E-book Bolton NHS Library Link to resource Not for loan local info note
E-book Bridgewater Community NHS Library Link to resource Not for loan local info note
E-book East Cheshire NHS Library Link to resource Not for loan local info note
E-book Greater Manchester Mental Health NHS Library Link to resource Not for loan local info note
E-book Mid Cheshire NHS Library Link to resource Not for loan local info note
E-book Pennine Care NHS Knowledge Service Link to resource Not for loan local info note
E-book Tameside and Glossop NHS Library Link to resource Not for loan local info note

Previous edition: Amsterdam; London: Elsevier, 2007.

Includes bibliographical references and index.

1. General Commentary on drug therapy and drug risks in pregnancy 2. Specific drug therapties during pregnancy 2.1 Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications 2.2 Allergy and hyosensitization therapy 2.3 Antiasthmatic and cough medication 2.4 Nausea and vomiting in pregnancy 2.5 Gastro-intestinal medications, hyoplipidemic agents and spasmolytics 2.6 Anti-infective Agents 2.7 Vaccines and immunoglobulins 2.8 Heart and blood medications 2.9 Anticoagulants, thrombocyte aggregation inhibitors, fibrinolyrics,and volume replacement agents 2.10 Epilepsy and antiepileptic medications 2.11 Psychotropic drugs 2.12 Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease 2.13 Antineoplastic drugs 2.14 Uterine contraction agents, tocolytics, vaginal therapeutics and local contraceptives 2.15 Hormones 2.16 General and local anesthetics and muscle relaxants 2.17 Dermatological medications and local therapeutics 2.18 Vitamins, minerals and trace elements 2.19 Herbs during pregnancy 2.20 Diagnostic agents 2.21 Recreational drugs 2.22 Poisonings and toxins 2.23 Occupational, industrial and environmental agents 3. General commentary on drug therapy and drug risk during lactation 3.1 The advances of breastfeading versus the risks of maternal medication 3.2 The passage of medication into the mother's milk 3.3 Infant characteristics 3.4 Milk plasma ratio 3.5 Amount of medication in the milk and relative dose 3.6 Toxicity of medications in the mother's milk 3.7 Medications that affect lactation 3.8 Breastfeeding support 4. Specific drug therapies during lactation 4.1 Analgesics, antiphlogistics and anesthetics 4.2 Antiallergics, antiasthmatics and antitussives 4.3 Gastrointestinal drugs 4.4 Anti-infectives 4.5 Vaccines and immunoglobulins 4.6 Cardiovascular drugs and diuretics 4.7 Anticoagulants, thrombocyte aggregation inhibitors and fibrinolytics 4.8 Antiepileptics 4.9 Psychotropic drugs 4.10 Immunomodulating and antineoplastic agents 4.11 Hormones and hormone antagonists 4.12 Dermatological medication and local therapeutics 4.13 Alternative remedies, vitamins, and minerals 4.14 Contrast media, radionuclides and diagnostics 4.15 Infections during breastfeeding 4.16 Recreational drugs 4.17 Plant toxins 4.18 Industrial chemicals and environmental contaminants 4.18.1 Persistent organochlorine compounds (pesticides, polychlorinated biphenyls and dioxins) 4.18.2 Mercury 4.18.3 Lead 4.18.4 Cadmium 4.18.5 Other contaminants 4.18.6 Breasfeeding despite environmental contaminants? 4.18.7 Breastfeeding and the workplace

This work presents the state of knowledge about drugs in pregnancy. In each chapter information is presented separately for two different aspects of the problem seeking a drug appropriate for prescription during pregnancy, and assessing the risk of a drug when exposure has already taken place. Drugs During Pregnancy and Lactation, 3 rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new medicinal products, this edition is a comprehensive resource covering latest knowledge and findings related to drugs during lactation and pregnancy. Provides evidence-based recommendations to help clinicians make appropriate recommendations Uniquely organized and structured according to drug class and treatment indications to offer authoritative clinical content on potential adverse effects Highlights new research developments from primary source about working mechanism of substances that cause developmental disorders

Also available in printed form ISBN 9780124080782

Electronic reproduction. Browns Books For Students. Mode of access: World Wide Web.